The effect of probiotic treatment withClostridium butyricumon enterohemorrhagicEscherichia coliO157:H7 infection in mice
Open Access
- 1 July 2004
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 41 (3), 219-226
- https://doi.org/10.1016/j.femsim.2004.03.010
Abstract
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 has been considered as an agent responsible for outbreak of hemorrhagic colitis and the hemolytic uremic syndrome. We examined the effect of the probiotic agent Clostridium butyricum MIYAIRI strain 588 on EHEC O157:H7 infections in vitro and in vivo using gnotobiotic mice. The growth of EHEC O157:H7 and the production of Shiga-like toxins in broth cultures were inhibited by co-incubation with C. butyricum. The antibacterial effects of butyric and lactic acid were demonstrated in a dose-dependent manner. In addition, the inhibitory effect of butyric acid on the viability of EHEC was demonstrated not only at low pH, but also at neutral pH adjusted to 7.0. Flowcytometric analysis showed that pre-incubation of Caco-2 cells with C. butyricum and E. coli K12 inhibited the adhesion of EHEC O157:H7. However, the effect of C. butyricum on adhesion of EHEC to Caco-2 cells was more inhibitory than that of E. coli K12. Gnotobiotic mice mono-associated with EHEC O157:H7 died within 4–7 days after the infection. On the other hand, all gnotobiotic mice prophylactically pre-treated with C. butyricum survived exposure to EHEC O157:H7 and of the gnotobiotic mice therapeutically post-treated with C. butyricum, 50% survived. Both counts of EHEC O157:H7 and the amounts of shiga-like toxins (Stx1 and Stx2) in fecal contents of gnotobiotic mice di-associated with EHEC O157:H7 and C. butyricum were less than those of gnotobiotic mice mono-associated with EHEC O157:H7. These results indicated that the probiotic bacterium C. butyricum MIYAIRI strain 588 has preventive and therapeutic effects on EHEC O157:H7 infection in gnotobiotic mice.Keywords
This publication has 29 references indexed in Scilit:
- Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic miceJournal of Medical Microbiology, 2000
- Probiotic Bacteria Stimulate Gut Epithelial Cell Proliferation in RatDigestive Diseases and Sciences, 1999
- Effects of Administration of Clostridium butyricum to Patients Receiving Long-Term Tube Feeding.Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 1997
- The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic SyndromeEpidemiologic Reviews, 1991
- A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.Proceedings of the National Academy of Sciences of the United States of America, 1990
- Illnesses Associated withEscherichia coli0157:H7 InfectionsAnnals of Internal Medicine, 1988
- Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomesEuropean Journal of Biochemistry, 1988
- Protection activity induced by the bacterial vaccine, heat-killed Clostridium butyricum against Candida albicans infections in mice.Japanese Journal of Medical Mycology, 1987
- Shiga and Shiga-like toxins.Microbiological Reviews, 1987
- The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coliThe Journal of Infectious Diseases, 1985